<DOC>
	<DOCNO>NCT00375505</DOCNO>
	<brief_summary>This study examine safety efficacy zoledronic acid 4 mg. , give every 3 month 24 month ( infusion month 0 , 3 , 6 , 9 , 12 , 15 , 18 21 ) improve bone mineral density premenopausal woman hormone receptor negative breast cancer adjuvant chemotherapeutic treatment</brief_summary>
	<brief_title>The Safety Efficacy Zoledronic Acid Prevention Cancer Therapy Induced Bone Loss</brief_title>
	<detailed_description />
	<mesh_term>Zoledronic acid</mesh_term>
	<mesh_term>Diphosphonates</mesh_term>
	<criteria>Female patient histologically confirm incident invasive breast cancer ( T14 ) positive hormone receptor status ( ER and/or PgR positive ) evidence regional lymph node metastasis ( N0 ) distant metastasis ( M0 ) Patient undergone complete primary tumor resection axillary lymph node dissection le 90 day start study drug treatment . Patient premenopausal diagnosis breast cancer ( spontaneous regular menses premenopausal estradiol level ( &gt; 10 ng/dL ) Patient receive adjuvant standard chemoendocrine endocrine therapy Bone density study entry &gt; 2.5 TScore History treatment disease affect bone metabolism ( e.g. , Paget 's disease , primary hyperparathyroidism ) , prior treatment bisphosphonates treatment osteoporosis addition calcium vitamin D Abnormal renal function Current active dental problem include infection teeth jawbone ( maxilla mandibular ) ; dental fixture trauma , current prior diagnosis osteonecrosis jaw ( ONJ ) , expose bone mouth , slow healing dental procedure , recent ( within 6 week ) plan dental jaw surgery ( e.g . extraction , implant ) Pregnancy lactation Women childbearing potential apply medically recognize form contraception ( i.e. , oral contraceptive implant , IUD , vaginal diaphragm sponge , condom spermicide ) Other protocoldefined inclusion/exclusion criterion may apply</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2015</verification_date>
	<keyword>Breast Cancer</keyword>
	<keyword>Premenopausal</keyword>
	<keyword>Bone mineral density</keyword>
	<keyword>Cancer therapy induce bone loss</keyword>
	<keyword>zoledronic acid</keyword>
</DOC>